Search results
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 3 hours agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 7 hours agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...
French, US drug firms team up for Covid-flu shot
Medical Xpress· 8 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialize Novavax's COVID-19 vaccine worldwide, except in some countries...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg· 13 hours agoHave a confidential tip for our reporters? Novavax Inc. shares surged after the company signed a...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 12 hours agoNovavax will also be entitled to a further $200 million in additional launch and sales milestone...
French, US drug firms team up for Covid-flu shot
AFP via Yahoo Finance· 10 hours agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 12 hours agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 14 hours agoSanofi agreed to pay Novavax $500 million upfront, with another $700 million in possible payments...
Novavax stock soars 120% as Sanofi deal 'kicks off a new chapter' By Investing.com
Investing.com· 12 hours agoAccording to Novavax CEO John Jacobs, the partnership will enable the company to lift its "going...
French, US drug firms team up for Covid-flu shot
Digital Journal· 2 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialise Novavax’s Covid-19 vaccine worldwide, except in some countries including ...
